Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features.
about
Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosusProlonged complete remission in previously severe SLEThe central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up study.Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests.Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now?Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology.Inactive disease and remission in childhood-onset systemic lupus erythematosusAnti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice.Pathogenic autoantibodies in lupus nephritis.The many faces of lupus.Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies.The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis.Is there a cure for systemic lupus erythematosus?Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.The anti-DNA antibody: origin and impact, dogmas and controversies.(5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.Systemic lupus erythematosus. Controversies in management.(5R)-5-hydroxytriptolide ameliorates anti-glomerular basement membrane glomerulonephritis in NZW mice by regulating Fcγ receptor signaling.The natural history of lupus erythematosus.Serological markers of disease activity in systemic lupus erythematosus.Clinical significance and correlation of anti-native DNA antibodies and immune complex level in systemic lupus erythematosus.The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period.Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year Period.Impaired phagocytosis of apoptotic cell material in serologically active clinically quiescent patients with systemic lupus erythematosis.Renal infarction due to lupus vasculopathy.Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease.
P2860
Q26776493-1CE3A765-4110-418C-84B5-7F5B8073A4A2Q33553455-FAB6EF2F-5200-41DC-8E75-39514CBBA8CCQ34234795-1430FC99-E67A-476A-85A6-714513A74EAAQ34430439-10B4E5D5-9477-492E-BAD3-BC117283A015Q34968807-6536196E-2CEB-41E8-9AAC-EB006AB4970BQ35045883-076E6E52-3EA2-42A6-9CE2-C7DF11C855D4Q35743185-A619B4A3-3316-478A-9B94-D3B33DCA858BQ35911531-9C9FF2F7-E3DF-4E6F-B8BE-C5CBB4F876E4Q35931319-DCA06D31-03E7-4876-8835-B0CCC78B8AB2Q36054822-7F51B217-A471-46DD-8AE3-F7A415FBB00AQ36520338-EF0B57C1-7A47-4EC1-A737-8E288F3AAF02Q37037746-4C53E490-8031-4E28-99F2-60A425EB5712Q37388844-4D4F8A23-750E-4359-9089-82885B1F72A2Q38095888-A7DC77F9-31E0-45A0-9EF6-77E3357A5DF1Q38237868-A4CFABE7-C86F-419C-BFC4-3024E6D9B742Q38512653-D8173C9F-FB21-42CC-A42E-C2B2A32FC3E1Q38720673-AF8F4B44-385B-46BF-8BF3-1BF072F266A2Q39656638-7E741782-3008-4D27-89A0-0A88504C590CQ40054103-FE55B908-55D2-47E3-9563-577DA42F2D7AQ40179650-11846EBF-CB17-4EB4-B49F-D4B598168105Q40552933-88DF0FF8-41CF-477F-9CCE-2E973524337FQ41179383-9159BCDE-A61D-48A8-8E72-05F1F3026603Q42234669-539FC94E-4925-44BF-B3C9-C6B5E2EAD115Q44068958-56860B25-5A41-4BC9-9348-D790F8BF782FQ44520690-993DC762-3E47-4770-BC3E-CC64AB2BF315Q47759350-E9C42696-3DC2-4AD9-BEBF-F1615BF15EE8Q47967726-BB6690DB-9211-43B1-B0CC-D7C6DC5BE510Q48067980-258F1286-CCE4-4EEC-BB99-FD0B5BB69155Q53623092-1DA04BF5-EFD7-4859-89A2-497A4F3C1621Q54795653-CABCE18B-E7B6-4DCE-A5AC-B6135E485465
P2860
Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Serologically active clinicall ...... inical and serologic features.
@en
type
label
Serologically active clinicall ...... inical and serologic features.
@en
prefLabel
Serologically active clinicall ...... inical and serologic features.
@en
P1476
Serologically active clinicall ...... inical and serologic features.
@en
P2093
E C Keystone
M B Urowitz
P304
P356
10.1016/0002-9343(79)90529-1
P407
P577
1979-02-01T00:00:00Z